Dhampur Bio Organics
DBOL NSE
Dhampur Bio Organics
Consumer GoodsNSE: DBOL BSE: 543593 Sugar
Key Fundamentals
MicrocapSugarConsumer GoodsMarket Cap
₹814 Cr
Volatility
Moderate
P/E Ratio
9.37
EBITDA
₹163 Cr
Return on Equity
2.45%
Debt to Equity
1.03
Book Value
₹154.64
52W High
₹139
52W Low
₹69
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Stock is trading at 0.77 times its book value
- Company has been maintaining a healthy dividend payout of 43.9%
Weaknesses
4- Company has low interest coverage ratio.
- Company has a low return on equity of 2.61% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.89.5 Cr.
Growth Rate
Revenue Growth
14.79% higher than
3Y
Net Income Growth
71.43% higher than
3Y
Cash Flow Change
69.68% lower than
3Y
ROE
68.97% higher than
3Y
ROCE
26.07% higher than
3Y
EBITDA Margin (Avg.)
2.43% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 583 | 538 | 280 | 463 | 467 | 466 | 464 | 464 | 492 | 558 | 486 | 460 | 533 |
| Expenses | 543 | 519 | 284 | 382 | 434 | 476 | 448 | 369 | 484 | 566 | 444 | 380 | 524 |
| Operating Profit | 41 | 19 | -4 | 81 | 33 | -10 | 16 | 96 | 9 | -8 | 43 | 80 | 9 |
| OPM % | 7% | 3.6% | -1.6% | 18% | 7% | -2.1% | 3.4% | 21% | 1.8% | -1.4% | 9% | 17% | 1.7% |
| Other Income | 2 | 1 | 16 | 5 | 1 | 1 | -1 | 1 | -6 | 13 | 9 | 15 | 52 |
| Interest | 13 | 9 | 6 | 18 | 21 | 16 | 10 | 20 | 19 | 14 | 11 | 14 | 16 |
| Depreciation | 11 | 10 | 14 | 14 | 12 | 11 | 15 | 16 | 12 | 15 | 15 | 13 | 13 |
| PBT | 18 | 0 | -8 | 54 | 1 | -35 | -10 | 61 | -29 | -23 | 26 | 69 | 32 |
| Tax % | 32% | 88% | -28% | 28% | 83% | -34% | -32% | 26% | -24% | -32% | 34% | 33% | -14% |
| Net Profit | 13 | 0 | -6 | 39 | 0 | -23 | -7 | 45 | -22 | -16 | 17 | 46 | 37 |
| EPS in Rs | 1.91 | 0.01 | -0.85 | 5.94 | 0.02 | -3.52 | -1.03 | 6.75 | -3.31 | -2.41 | 2.55 | 6.97 | 5.54 |
Profit & Loss
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 1,564 | 2,408 | 1,864 | 1,862 | 2,109 | 2,036 |
| Expenses | 0 | 1,381 | 2,203 | 1,724 | 1,727 | 1,976 | 1,913 |
| Operating Profit | 0 | 183 | 205 | 140 | 135 | 133 | 124 |
| OPM % | — | 12% | 8% | 8% | 7% | 6% | 6% |
| Other Income | 0 | 8 | 11 | 20 | 2 | 29 | 89 |
| Interest | 0 | 30 | 41 | 45 | 67 | 63 | 54 |
| Depreciation | 0 | 31 | 41 | 49 | 54 | 59 | 55 |
| PBT | 0 | 129 | 135 | 65 | 16 | 41 | 103 |
| Tax % | 0% | 21% | 18% | 29% | 6% | 38% | — |
| Net Profit | 0 | 102 | 111 | 46 | 15 | 25 | 84 |
| EPS in Rs | — | — | 16.74 | 7 | 2.21 | 3.79 | 12.65 |
| Div. Payout % | 0% | 0% | 21% | 36% | 56% | 40% | — |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 66 | 66 | 66 | 66 | 66 | 66 |
| Reserves | 709 | 812 | 922 | 945 | 945 | 960 |
| Borrowings | 403 | 835 | 810 | 1,057 | 1,162 | 1,060 |
| Other Liabilities | 373 | 287 | 278 | 244 | 223 | 235 |
| Total Liabilities | 1,551 | 2,000 | 2,077 | 2,313 | 2,398 | 2,322 |
| Fixed Assets | 631 | 690 | 909 | 1,036 | 1,076 | 1,131 |
| CWIP | 7 | 78 | 36 | 13 | 79 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 2 |
| Other Assets | 913 | 1,232 | 1,132 | 1,263 | 1,242 | 1,188 |
| Total Assets | 1,551 | 2,000 | 2,077 | 2,313 | 2,398 | 2,322 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | 0 | -246 | 368 | -101 | 130 | 220 |
| Investing | 0 | -124 | -209 | -166 | -145 | -42 |
| Financing | 0 | 393 | -78 | 170 | 19 | -178 |
| Net Cash Flow | 0 | 23 | 81 | -98 | 3 | 0 |
| Free Cash Flow | 0 | -389 | 158 | -245 | -15 | 177 |
| CFO/OP | 100 | -122 | 191 | -60 | 102 | 164 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | — | 25 | 23 | 17 | 11 | 11 |
| Inventory Days | — | 341 | 163 | 288 | 288 | 231 |
| Days Payable | — | 54 | 33 | 37 | 29 | 26 |
| Cash Conversion Cycle | — | 312 | 154 | 269 | 270 | 216 |
| Working Capital Days | — | 56 | 24 | 33 | 21 | 23 |
| ROCE % | — | 11% | 10% | 5% | 4% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Dhampur Bio Organics insights
59 extracted metrics + investor summaries across FY21–FY27.
Documents
1
Announcement under Regulation 30 (LODR)-Demise
1d - Chairman and Executive Director Vijay Kumar Goel died on May 10, 2026. 1d - Chairman and Executive Director Vijay Kumar Goel died on May 10, 2026.
2
Announcement under Regulation 30 (LODR)-Change in Management
7 May - Vice President-Cane Mohd. Rizwan Khan resigned effective close of business May 7, 2026. 7 May - Vice President-Cane Mohd. Rizwan Khan resigned effective close of business May 7, 2026.
3
Announcement under Regulation 30 (LODR)-Newspaper Publication
29 Apr - Launch of second 100 days campaign - "Saksham Niveshak 2.0" by IEPFA read with Regulation 47 of SEBI (LODR) Regulations, 2015, we enclose herewith the … 29 Apr - Launch of second 100 days campaign - "Saksham Niveshak 2.0" by IEPFA read with Regulation 47 of SEBI (LODR) Regulations, 2015, we enclose herewith the …
4
Announcement under Regulation 30 (LODR)-Newspaper Publication
29 Apr - Launch of second 100 days campaign - "Saksham Niveshak 2.0" by IEPFA read with Regulation 47 of SEBI (LODR) Regulations, 2015, we enclose herewith the … 29 Apr - Launch of second 100 days campaign - "Saksham Niveshak 2.0" by IEPFA read with Regulation 47 of SEBI (LODR) Regulations, 2015, we enclose herewith the …
5
Announcement under Regulation 30 (LODR)-Newspaper Publication
25 Apr - Read with regulation 47 of SEBI (LODR) Regulations, 2015, we enclose herewith copies of Business Standard (English and Hindi) both dated April 25, 2026 regarding … 25 Apr - Read with regulation 47 of SEBI (LODR) Regulations, 2015, we enclose herewith copies of Business Standard (English and Hindi) both dated April 25, 2026 regarding …
Frequently Asked Questions about Dhampur Bio Organics
What does Dhampur Bio Organics Ltd do?
Incorporated in 2022, Dhampur Bio Organics Ltd manufactures sugar, chemicals, ethanol,
co-generation of power and other allied products[1]
Where is Dhampur Bio Organics Ltd (DBOL) listed?
Dhampur Bio Organics Ltd trades as DBOL on the NSE and under code 543593 on the BSE.
Which sector does Dhampur Bio Organics Ltd belong to?
Dhampur Bio Organics Ltd is classified under the Consumer Goods sector, in the Sugar industry.
What is the market capitalisation of Dhampur Bio Organics Ltd?
Dhampur Bio Organics Ltd has a market capitalisation of ₹814.04 Cr, which places it in the Small Cap band.
What is the PE ratio of Dhampur Bio Organics Ltd?
Dhampur Bio Organics Ltd trades at a PE ratio of 9.37, against a book value of ₹154.64 per share.
What is the 52-week high and low of Dhampur Bio Organics Ltd?
Over the last 52 weeks Dhampur Bio Organics Ltd has traded between ₹69 and ₹139.
Does Dhampur Bio Organics Ltd pay dividends?
Dhampur Bio Organics Ltd has a dividend yield of 1.25%.
What is the Return on Equity (ROE) of Dhampur Bio Organics Ltd?
Dhampur Bio Organics Ltd reported a return on equity of 2.45%. Its debt-to-equity ratio is 1.03.
Company Information
Incorporated in 2022, Dhampur Bio Organics Ltd manufactures sugar, chemicals, ethanol, co-generation of power and other allied products[1]
Website dhampur.com
CEO Mr. Vijay Kumar Goel
Employees 1,657
Listed 2022-09-08
Face Value ₹ 10
Issued Size 6,63,87,590
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DBOL.md for Dhampur Bio Organics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.